- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0015979

Arrios Pharmaceuticals Private Limited
About Arrios Pharmaceuticals Private Limited
Data last updated:
Arrios Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 02 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC327888. Its GSTIN is 07AAQCA3860M1Z5 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amita Sharma and Jyoti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 84 Dsidc Centre Kotla Mubarak Pur, New Delhi, Delhi, India – 110003.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.9 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹1.09 Lakh (net margin -6.8%) and EBITDA of -₹1.09 Lakh (EBITDA margin -6.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
Arrios Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0015979).
Company details
Recognitions & Rankings of Arrios Pharmaceuticals
Contact details
Arrios Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address84 Dsidc Centre Kotla Mubarak Pur, New Delhi, Delhi, India – 110003
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Arrios Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arrios Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Arrios Pharmaceuticals Private Limited, buy the company report.
Financials of Arrios Pharmaceuticals Private Limited
FY 2025 filings availableArrios Pharmaceuticals Private Limited reported revenue of ₹15.9 Lakh (down 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 147% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.8% | ||||
| Net Profit Margin | -6.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arrios Pharmaceuticals Private Limited, buy the company report.
Board of directors of Arrios Pharmaceuticals Private Limited
Arrios Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amita Sharma | Additional Director | 18 Oct 2021 | 5 Years 0 Months | Current |
| Jyoti | Additional Director | 19 Feb 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Arrios Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arrios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arrios Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCA3860M1Z5 | Delhi | Active | 10 May 2018 |
To see the full GST registrations and return filing status of Arrios Pharmaceuticals Private Limited, buy the company report.
Recent activity
Arrios Pharmaceuticals Private Limited has 10 board changes on record since 2018: 6 appointments and 4 cessations. The latest: Amit Sharma ceased to be Director on 06 Jun 2025.
1 earlier event is in the company report.
Frequently asked questions
Arrios Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 02 January 2018 (8+ years old) and is registered under CIN U74999DL2018PTC327888.
Arrios Pharmaceuticals has 2 current directors:
- Amita Sharma - Additional Director
- Jyoti - Additional Director
The latest financial statements of Arrios Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Arrios Pharmaceuticals is 07AAQCA3860M1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Arrios Pharmaceuticals is U74999DL2018PTC327888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arrios Pharmaceuticals was incorporated on 02 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Sharma ceased to be Director on 06 Jun 2025. Jyoti was appointed as Additional Director on 19 Feb 2022. Amita Sharma was appointed as Additional Director on 18 Oct 2021. Arrios Pharmaceuticals has 10 board changes on record in total.
Yes, Arrios Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0015979).
The registered office of Arrios Pharmaceuticals is at 84 Dsidc Centre Kotla Mubarak Pur, New Delhi, Delhi, India – 110003.
Arrios Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.

